245 SUMMER STREET,
BOSTON , MA, 02210
BOSTON , MA, 02210
Summary
The fund seeks to replicate the total return performance of the benchmark index, before fees and expenses, by investing in companies across any size in the United States.
The sub-adviser’s investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.
Next, the research team invests signific More
Webiste
Directors
Oct 16, 2023- David M. Thomas
- Thomas P. Bostick
- Vicki L. Fuller
- Patricia L. Kampling
- Susan Tomasky
- Bettina Doulton
- Michael E. Wiley
- Thomas A. Kennedy
- Oscar Munoz
- Robert A. Lawrence
- Dennis J. Dirks
- Donald F. Donahue
- Garnett A. Smith
Chief Compliance Officer
- Jason P. Pogorelec
Price
- $ 63 ( -2.94 )
-
Apr 10, 2025Last Close
- Net Assets
-
$3.1B
Mar 26, 2024
- 52-Week High/Low
- $74.2 - $61.9
- Expense Ratio
- -
Performance
YTD
0%
3 Year
-7.46%
5 Year
37.05%
Best
36.39%
2006
Worst
-27.48%
2000
Company Name |
Holding |
| Eli Lilly & Co | 10.28 % |
| UnitedHealth Group Inc | 8.4 % |
| Johnson & Johnson | 6.01 % |
| AbbVie Inc | 5.19 % |
| Merck & Co Inc | 4.53 % |
| Thermo Fisher Scientific Inc | 3.7 % |
| Danaher Corp | 3.08 % |
| Abbott Laboratories | 2.91 % |
| Amgen Inc | 2.82 % |
| Pfizer Inc | 2.73 % |
| More | 2.73 % |
Documents
NAV
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FHLC | 0% | 3.2% | 1.1% | -6.2% | 19.2% | 15% | 20.8% | 5.5% | 23.4% | -3.4% | |
| S&P 500 | -6.1% | 23.3% | 24.2% | -19.4% | 27.3% | 16.2% | 28.9% | -6.2% | 19.4% | 9.5% |
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| q1 | 0% | 7.9% | -3.9% | -3.7% | 2.1% | -13.6% | 8.1% | -0.1% | 9% | -7.1% | ||||
| q2 | 0% | -2.3% | 2.7% | -7.6% | 9.1% | 15.8% | 1% | 6.8% | 7.6% | 6.1% | ||||
| q3 | 0% | 0% | -4% | -5% | 0.1% | 4.6% | -4.2% | 13.2% | 3.6% | 2.3% | ||||
| q4 | 0% | 0% | 7.1% | 11% | 7.6% | 9.9% | 14.7% | -11% | 0.6% | -4.2% |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 2024 | 2.3% | 3.3% | 2% | -5.3% | 2.8% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |